This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4rlk
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Crystal structure of Z. mays CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate== | ==Crystal structure of Z. mays CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate== | ||
| - | <StructureSection load='4rlk' size='340' side='right' caption='[[4rlk]], [[Resolution|resolution]] 1.24Å' scene=''> | + | <StructureSection load='4rlk' size='340' side='right'caption='[[4rlk]], [[Resolution|resolution]] 1.24Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4rlk]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RLK OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[4rlk]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Zea_mays Zea mays]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RLK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4RLK FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=E91:4-[(E)-(9H-FLUOREN-9-YLIDENEHYDRAZINYLIDENE)METHYL]BENZOIC+ACID'>E91</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.24Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=E91:4-[(E)-(9H-FLUOREN-9-YLIDENEHYDRAZINYLIDENE)METHYL]BENZOIC+ACID'>E91</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4rlk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rlk OCA], [https://pdbe.org/4rlk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4rlk RCSB], [https://www.ebi.ac.uk/pdbsum/4rlk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4rlk ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/CSK2A_MAIZE CSK2A_MAIZE] Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 16: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4rlk" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Casein kinase 3D structures|Casein kinase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Boldyreff | + | [[Category: Zea mays]] |
| - | [[Category: Guerra | + | [[Category: Boldyreff BS]] |
| - | [[Category: Issinger | + | [[Category: Guerra B]] |
| - | [[Category: Jensen | + | [[Category: Issinger OG]] |
| - | [[Category: Marcussen | + | [[Category: Jensen HH]] |
| - | [[Category: Miyata | + | [[Category: Marcussen N]] |
| - | [[Category: Niefind | + | [[Category: Miyata Y]] |
| - | [[Category: Rasmussen | + | [[Category: Niefind K]] |
| - | [[Category: Schnitzler | + | [[Category: Rasmussen TDL]] |
| - | + | [[Category: Schnitzler A]] | |
| - | + | ||
Current revision
Crystal structure of Z. mays CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate
| |||||||||||
Categories: Large Structures | Zea mays | Boldyreff BS | Guerra B | Issinger OG | Jensen HH | Marcussen N | Miyata Y | Niefind K | Rasmussen TDL | Schnitzler A
